Overexpression of GPNMB predicts an unfavorable outcome of epithelial ovarian cancer
Author:
Funder
the National Key Research and Development Programme of China
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynaecology,General Medicine
Link
http://link.springer.com/article/10.1007/s00404-018-4699-3/fulltext.html
Reference31 articles.
1. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63:11–30. https://doi.org/10.3322/caac.21166
2. Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61:212–236. https://doi.org/10.3322/caac.20121
3. Amate P, Huchon C, Dessapt AL et al (2013) Ovarian cancer: sites of recurrence. Int J Gynecol Cancer 23:1590–1596. https://doi.org/10.1097/IGC.0000000000000007
4. Owen TA, Smock SL, Prakash S et al (2003) Identification and characterization of the genes encoding human and mouse osteoactivin. Crit Rev Eukaryot Gene Expr 13:205–220. https://doi.org/10.1615/CritRevEukaryotGeneExpr.v13.i24.130
5. Weterman MA, Ajubi N, van Dinter IM et al (1995) nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts. Int J Cancer 60:73–81. https://doi.org/10.1002/ijc.2910600111
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Spatial transcriptomics reveals discrete tumour microenvironments and autocrine loops within ovarian cancer subclones;Nature Communications;2024-04-03
2. HOMER3 promotes liver hepatocellular carcinoma cancer progression by -upregulating EZH2 and mediating miR-361/GPNMB axis;Pathology - Research and Practice;2024-02
3. GPNMB Expression Associates with Inferior Prognosis in Patients with Small Cell Lung Cancer;Journal of Cancer;2024
4. Construction of a prognostic model for radical esophagectomy based on immunohistochemical prognostic markers combined with clinicopathological factors;Medicine;2023-03-03
5. miR-532–3p suppresses proliferation and invasion of ovarian cancer cells via GPNMB/HIF-1α/HK2 axis;Pathology - Research and Practice;2022-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3